The results revealed that hTERT-HPNE cells had relatively low FTH1 expression, whereas the FTH1 levels in the KRAS-mutant pancreatic cancer cell lines Mia PaCa-2 and SUIT-2 were approximately 18- and 13-fold higher, respectively, than those in hTERT-HPNE cells (Fig. 2b). The gene discussed is KRAS; the disease is pancreatic neoplasm.